Halozyme Therapeutics Inc (HALO) short volume · P/E 15, rev $857.7M
Halozyme Therapeutics Inc FINRA short-volume cache. Latest 2026-09-08.
| Date | Short | Total | Short % |
|---|---|---|---|
| 2026-09-08 | 319,302 | 744,031 | 42.9% |
| 2026-09-04 | 161,116 | 407,349 | 39.6% |
| 2026-09-03 | 540,856 | 891,587 | 60.7% |
| 2026-09-02 | 393,914 | 688,513 | 57.2% |
| 2026-09-01 | 214,603 | 412,460 | 52.0% |
| 2026-08-31 | 147,144 | 416,590 | 35.3% |
| 2026-08-28 | 206,509 | 578,074 | 35.7% |
| 2026-08-27 | 233,450 | 566,904 | 41.2% |
| 2026-08-26 | 166,053 | 510,486 | 32.5% |
| 2026-08-25 | 443,471 | 728,860 | 60.8% |
FAQ
What is HALO P/E and revenue?
Halozyme Therapeutics Inc (HALO) P/E 15, rev $857.7M.
What is HALO short volume?
Halozyme Therapeutics Inc last cached short volume is 42.9% of total volume on 2026-09-08.
Not investment advice. Cached rows, not a live tape.